Evidence map›Paper›PMID 20022966›Full record

ArticleThe Journal of biological chemistry2010

Nuclear localization of the p75 neurotrophin receptor intracellular domain.

Christopher N Parkhurst, Niccoló Zampieri, Moses V Chao

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed
2.1field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 67 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Nerve growth factor receptors in equine synovial membranes vary with osteoarthritic disease severity.Journal of orthopaedic research : official publication of the Orthopaedic Research Society · 2023
    Article
  5. Differential contribution of TrkB and p75Frontiers in molecular neuroscience · 2023
    Article
  6. Article
  7. Article
  8. The p75FEBS open bio · 2021
    Article
  9. Article
  10. Review
  11. Article
  12. Expression of cancer stem cell markers CD44, ALDH1 and p75NTR in actinic cheilitis and lip cancer.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery · 2018
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Detection of p75NTR Trimers: Implications for Receptor Stoichiometry and Activation.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2015
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Christopher N ParkhurstMolecular Neurobiology Program, Skirball Institute for Biomolecular Medicine, New York University School of Medicine, New York, New York 10016, USA.
Niccoló Zampieri
Moses V Chao
New York University · US

Funding

Gamma-Secretase cleavage of the p75 receptorR01AG025970 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2006 to 2016
$3.3M
Regulation of BACE1 by trophic factor signalingR56AG025970 · NIA · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI CHAO, MOSES VICTOR · 2018 to 2018
$494k
NIA NIH HHS AG025970NIA NIH HHS R01 AG025970NIA NIH HHS R56 AG025970
6 · The paper itself

Abstract

The p75 neurotrophin receptor, a member of the tumor necrosis factor superfamily of receptors, undergoes an alpha-secretase-mediated release of its extracellular domain, followed by a gamma-secretase-mediated intramembrane cleavage. Like amyloid precursor protein and Notch, gamma-secretase cleavage of the p75 receptor releases an intracellular domain (ICD). However, it has been experimentally challenging to determine the precise subcellular localization and functional consequences of the p75 ICD. Here, we utilized a nuclear translocation assay and biochemical fractionation approaches to follow the fate of the ICD. We found that the p75 ICD can translocate to the nucleus to activate a green fluorescent protein reporter gene. Furthermore, the p75 ICD was localized in nuclear fractions. Chromatin immunoprecipitation experiments indicated that nerve growth factor induced the association of endogenous p75 with the cyclin E(1) promoter. Expression of the p75 ICD resulted in modulation of gene expression from this locus. These results suggest that the p75 ICD generated by gamma-secretase cleavage is capable of modulating transcriptional events in the nucleus.

Indexed as

Active Transport, Cell NucleusAmyloid Precursor Protein SecretasesAnimalsCell NucleusCyclin EHeLa CellsHumansNerve Growth FactorNerve Tissue ProteinsOncogene ProteinsPC12 CellsPromoter Regions, GeneticProtein Structure, TertiaryRatsReceptors, Growth FactorReceptors, Nerve Growth FactorAmyloid Precursor Protein SecretasesCCNE1 protein, humanCyclin ENerve Growth FactorNerve Tissue ProteinsNGFR protein, humanNgfr protein, ratOncogene ProteinsReceptors, Growth FactorReceptors, Nerve Growth Factor

Identifiers

PMID20022966
PMCPMC2820764
OpenAlexW2004108587

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.